Table 1.
Quality Score Metrics
| Major Problems (5 Points) | Moderate Problems (3 Points) | Minor Problems (1 Point) |
|---|---|---|
| High levels of baseline missingness | Cancer status missing | Cancer status unknown |
| Large number of unknowns | ECOG performance status missing | ECOG performance status unknown |
| 30-day f/u is 60+ days overdue | 30-day f/u is 30–59 days overdue | |
| Death status missing or unknown | Metastatic status missing or unknown | |
| Baseline COVID-19 severity missing or unknown | ICU status missing or unknown | |
| Hospitalization status missing or unknown | ||
| Intubation status missing or unknown | ||
| O2 need missing or unknown | ||
| Days to death missing or unknown | ||
| ADT missing or unknown (prostate cancer only) | ||
| Biomarkers missing or unknown (breast cancer only) | ||
| BCG exposure missing or unknown (bladder cancer only) |
ADT, androgen deprivation therapy; BCG, Bacillus Calmette-Guérin; ECOG, Eastern Cooperative Oncology Group.